Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.20−0.03 (-12.85%)
Close on Nov 17, 2026Market cap $1.23MP/E –Yield –
Co-Diagnostics net income
Net income is the profit left for shareholders after every expense, interest and tax.
Co-Diagnostics's net income for the twelve months ending Jun 30, 2026 was -$47.06M. For fiscal 2025 it was -$46.90M. The highest annual figure on record is $42.48M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$46.90M | – |
| FY2024 | Dec 31, 2024 | -$37.64M | – |
| FY2023 | Dec 31, 2023 | -$35.33M | – |
| FY2022 | Dec 31, 2022 | -$14.24M | -138.8% |
| FY2021 | Dec 31, 2021 | $36.66M | -13.7% |
| FY2020 | Dec 31, 2020 | $42.48M | – |
| FY2019 | Dec 31, 2019 | -$6.20M | – |
| FY2018 | Dec 31, 2018 | -$6.27M | – |
| FY2017 | Dec 31, 2017 | -$6.96M | – |
| FY2016 | Dec 31, 2016 | -$1.93M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.28M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$25.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.89M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.53M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.03M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.60M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.68M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.98M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.92M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.76M | -149.1% |
| Q4 FY2022 | Dec 31, 2022 | -$21.91M | -392.1% |
| Q3 FY2022 | Sep 30, 2022 | -$1.36M | -111.9% |
| Q2 FY2022 | Jun 30, 2022 | -$2.69M | -127.5% |
| Q1 FY2022 | Mar 31, 2022 | $11.71M | +48.3% |
| Q4 FY2021 | Dec 31, 2021 | $7.50M | -41.5% |
| Q3 FY2021 | Sep 30, 2021 | $11.48M | -27.1% |
| Q2 FY2021 | Jun 30, 2021 | $9.79M | -34.8% |
| Q1 FY2021 | Mar 31, 2021 | $7.90M | – |
| Q4 FY2020 | Dec 31, 2020 | $12.81M | – |
| Q3 FY2020 | Sep 30, 2020 | $15.73M | – |
| Q2 FY2020 | Jun 30, 2020 | $15.01M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.07M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.74M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.75M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.34M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.37M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.95M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.64M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.37M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.31M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.50M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.89M | – |
| Q2 FY2017 | Jun 30, 2017 | -$855.01K | – |
| Q1 FY2017 | Mar 31, 2017 | -$705.74K | – |
| Q4 FY2016 | Dec 31, 2016 | -$525.25K | – |
| Q3 FY2016 | Sep 30, 2016 | -$449.95K | – |
See a number that looks wrong?